Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended		6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Revenue	$ 0	$ 0
Operating expenses:
General and administrative (including stock-based compensation (Note 8))	526,558	824,947	1,631,562	3,008,217
Depreciation	244,307	246,747	490,303	412,537
Research and development (including stock-based compensation (Note 8))	(120,003)	37,713	(53,445)	86,319
Total operating expenses	650,862	1,109,407	2,068,420	3,507,073
Loss from operations	(650,862)	(1,109,407)	(2,068,420)	(3,507,073)
Interest expense	88,606	72,022	174,717	127,288
Other expense			1,918
	88,606	72,022	176,635	127,288
Net loss	(739,468)	(1,181,429)	(2,245,055)	(3,634,361)
Net loss attributable to the noncontrolling interest	1,444	1,393	2,738	2,791
Net loss attributable to Bion	(738,024)	(1,180,036)	(2,242,317)	(3,631,570)
Dividends on preferred stock	(500)	(1,250)	(1,000)	(2,917)
Net loss applicable to Bion's common stockholders	$ (738,524)	$ (1,181,286)	$ (2,243,317)	$ (3,634,487)
Net loss applicable to Bion's common stockholders per basic and diluted common share (in Dollars per share)	$ (0.04)	$ (0.07)	$ (0.12)	$ (0.21)
Weighted-average number of common shares outstanding:
Basic and diluted (in Shares)	18,405,229	17,196,001	18,230,127	17,061,635